RAYMOND JAMES & ASSOCIATES - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$379,473
+26.5%
10,474
+7.4%
0.00%
Q2 2021$300,000
-18.3%
9,755
-30.5%
0.00%
Q1 2021$367,000
-27.8%
14,036
-30.5%
0.00%
-100.0%
Q4 2020$508,000
+19.0%
20,193
-1.3%
0.00%0.0%
Q3 2020$427,000
-1.8%
20,467
+11.7%
0.00%0.0%
Q2 2020$435,0000.0%18,327
-24.2%
0.00%0.0%
Q1 2020$435,000
-21.9%
24,189
+3.0%
0.00%0.0%
Q4 2019$557,000
-60.6%
23,483
-54.3%
0.00%
-50.0%
Q3 2019$1,413,000
-6.7%
51,409
+12.4%
0.00%0.0%
Q2 2019$1,514,000
-0.6%
45,743
+5.2%
0.00%0.0%
Q1 2019$1,523,000
-0.4%
43,472
-5.6%
0.00%
-33.3%
Q4 2018$1,529,000
+233.8%
46,034
+406.3%
0.00%
+200.0%
Q3 2018$458,000
-25.9%
9,092
-11.9%
0.00%0.0%
Q2 2018$618,000
+54.1%
10,319
+17.8%
0.00%0.0%
Q1 2018$401,000
+39.7%
8,762
+21.8%
0.00%0.0%
Q4 2017$287,000
-24.1%
7,192
-23.9%
0.00%0.0%
Q3 2017$378,000
+8.9%
9,454
+17.3%
0.00%0.0%
Q2 2017$347,000
+40.5%
8,058
+1.9%
0.00%0.0%
Q1 2017$247,000
-61.0%
7,907
-68.5%
0.00%
-50.0%
Q4 2016$634,000
+20.3%
25,117
+18.0%
0.00%
+100.0%
Q3 2016$527,000
+23.1%
21,294
+1.3%
0.00%0.0%
Q2 2016$428,000
+5.9%
21,024
-20.7%
0.00%0.0%
Q1 2016$404,000
+98.0%
26,511
+74.4%
0.00%0.0%
Q4 2015$204,000
-63.9%
15,199
-62.2%
0.00%
-50.0%
Q3 2015$565,00040,2410.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders